Filing Details
- Accession Number:
- 0001415889-24-006053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-01 15:06:55
- Reporting Period:
- 2024-02-28
- Accepted Time:
- 2024-03-01 15:06:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597264 | Blueprint Medicines Corp | BPMC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1718648 | K. Christopher Murray | C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139 | Chief Technical Operations | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-28 | 5,000 | $54.13 | 29,495 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 5,000 | $100.00 | 24,495 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-28 | 5,000 | $0.00 | 5,000 | $54.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,000 | 2030-03-01 | No | 4 | M | Direct |
Footnotes
- Effected pursuant to a trading plan adopted on June 5, 2023 in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This option was granted on March 1, 2020. This option vested with respect to 1/48th of the shares underlying the option on April 1, 2020 and as to an additional 1/48th of the shares underlying the option each month thereafter.
Billionaire Hedge Funds
